Literature DB >> 32297957

A review of HLA allele and SNP associations with highly prevalent infectious diseases in human populations.

Alicia Sanchez-Mazas1.   

Abstract

Human leucocyte antigen (HLA) alleles and single nucleotide polymorphisms (SNPs) lying in the HLA region are known to be associated with several infectious diseases among which acquired immunodeficiency syndrome, hepatitis B, hepatitis C, tuberculosis, leprosy and malaria are highly prevalent in many human populations worldwide. Distinct approaches such as case-control comparisons, immunogenetic analyses, bioinformatic peptide-binding predictions, ancient DNA and genome-wide association studies (GWAS) have contributed to improving this knowledge during the last decade, although many results still need stronger statistical and/or functional support. The present review updates the information regarding the main HLA allele and SNP associations observed to date for six of the most widespread and some other infectious diseases, and provides a synthetic illustration of these findings on a schematic HLA genomic map. It then discusses these results by stressing the importance of integrating information on HLA population diversity in disease-association studies.

Entities:  

Year:  2020        PMID: 32297957     DOI: 10.4414/smw.2020.20214

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  9 in total

1.  A large-scale investigation into the role of classical HLA loci in multiple types of severe infections, with a focus on overlaps with autoimmune and mental disorders.

Authors:  Ron Nudel; Rosa Lundbye Allesøe; Wesley K Thompson; Thomas Werge; Simon Rasmussen; Michael E Benros
Journal:  J Transl Med       Date:  2021-05-31       Impact factor: 5.531

2.  Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality.

Authors:  Atsushi Sakuraba; Haider Haider; Toshiro Sato
Journal:  Viruses       Date:  2020-11-20       Impact factor: 5.048

Review 3.  Current HLA Investigations on SARS-CoV-2 and Perspectives.

Authors:  Venceslas Douillard; Erick C Castelli; Steven J Mack; Jill A Hollenbach; Pierre-Antoine Gourraud; Nicolas Vince; Sophie Limou
Journal:  Front Genet       Date:  2021-11-29       Impact factor: 4.599

4.  How HLA diversity is apportioned: influence of selection and relevance to transplantation.

Authors:  André Silva Maróstica; Kelly Nunes; Erick C Castelli; Nayane S B Silva; Bruce S Weir; Jérôme Goudet; Diogo Meyer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-04-18       Impact factor: 6.671

5.  Challenging Ancient DNA Results About Putative HLA Protection or Susceptibility to Yersinia pestis.

Authors:  Da Di; Jeanne Simon Thomas; Mathias Currat; José Manuel Nunes; Alicia Sanchez-Mazas
Journal:  Mol Biol Evol       Date:  2022-04-10       Impact factor: 8.800

Review 6.  Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions.

Authors:  Mina Mobini Kesheh; Sara Shavandi; Parastoo Hosseini; Rezvan Kakavand-Ghalehnoei; Hossein Keyvani
Journal:  Biomed Res Int       Date:  2021-05-28       Impact factor: 3.411

7.  MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.

Authors:  Shay Ben Shachar; Noam Barda; Sigal Manor; Sapir Israeli; Noa Dagan; Shai Carmi; Ran Balicer; Bracha Zisser; Yoram Louzoun
Journal:  J Clin Immunol       Date:  2021-05-29       Impact factor: 8.317

8.  Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.

Authors:  Rodrigo Barquera; Evelyn Collen; Da Di; Stéphane Buhler; João Teixeira; Bastien Llamas; José M Nunes; Alicia Sanchez-Mazas
Journal:  HLA       Date:  2020-06-11       Impact factor: 8.762

9.  Unique Pathogen Peptidomes Facilitate Pathogen-Specific Selection and Specialization of MHC Alleles.

Authors:  Onur Özer; Tobias L Lenz
Journal:  Mol Biol Evol       Date:  2021-09-27       Impact factor: 16.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.